Literature DB >> 12381494

Depression in Alzheimer's disease: is there a temporal relationship between the onset of depression and the onset of dementia?

Reinhard Heun1, Martin Kockler, Ursula Ptok.   

Abstract

Alzheimer's disease (AD) patients often present with concurrent major depression (MD). To investigate the reasons for this comorbidity, e.g. MD being a risk factor for AD, or both diagnoses having a common neurobiology, the temporal relationship between the first onset of AD and of MD during lifetime was investigated-57 out of 146 AD patients had a lifetime diagnosis of MD. The correlation between the ages at onset of MD and dementia was calculated. The incidence of MD in AD patients in several 5-year-intervals before and after the onset of AD was compared with the average incidence of MD in the present AD sample and with the expected incidence of MD in the general population. No significant correlation between the onset of AD and of MD could be found after controlling for age, gender and the Mini-Mental-State. However, the incidence of MD 5 years before and after the onset of AD significantly exceeded the expected incidences-MD is only partially related to AD. However, the increased incidence of MD within 5 years before and after the onset of dementia may indicate that a common neurobiological process causes cognitive decline and depression in a subsample of AD patients.

Entities:  

Mesh:

Year:  2002        PMID: 12381494     DOI: 10.1016/s0924-9338(02)00678-8

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  9 in total

1.  Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; Tasnime N Akbaraly; Michael Marmot; Maria Melchior; Joël Ankri; Séverine Sabia; Jane E Ferrie
Journal:  J Clin Psychiatry       Date:  2010-06-01       Impact factor: 4.384

2.  Soluble amyloid-β levels and late-life depression.

Authors:  Ricardo S Osorio; Tyler Gumb; Nunzio Pomara
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Spousal caregiving, widowhood, and cognition: A systematic review and a biopsychosocial framework for understanding the relationship between interpersonal losses and dementia risk in older adulthood.

Authors:  E Lydia Wu-Chung; Stephanie L Leal; Bryan T Denny; Samantha L Cheng; Christopher P Fagundes
Journal:  Neurosci Biobehav Rev       Date:  2021-12-29       Impact factor: 8.989

Review 4.  Stress-Induced Depression and Alzheimer's Disease: Focus on Astrocytes.

Authors:  Oleg V Dolotov; Ludmila S Inozemtseva; Nikolay F Myasoedov; Igor A Grivennikov
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

5.  Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia.

Authors:  Deborah E Barnes; Kristine Yaffe; Amy L Byers; Mark McCormick; Catherine Schaefer; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2012-05

6.  Hippocampus atrophy and the longitudinal course of late-life depression.

Authors:  Warren D Taylor; Douglas R McQuoid; Martha E Payne; Anthony S Zannas; James R MacFall; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2013-11-22       Impact factor: 4.105

Review 7.  Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.

Authors:  Rossana Botto; Nicoletta Callai; Aurora Cermelli; Lorenzo Causarano; Innocenzo Rainero
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.830

8.  Ethnic Differences in Loneliness, Depression, and Malnutrition Among Older Adults During COVID-19 Quarantine.

Authors:  A V Schorr; I Yehuda; S Tamir
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 5.285

9.  Pattern of inpatient care for depression: an analysis of 232,289 admissions.

Authors:  Gernot Fugger; Thomas Waldhör; Barbara Hinterbuchinger; Nathalie Pruckner; Daniel König; Andrea Gmeiner; Sandra Vyssoki; Benjamin Vyssoki; Matthäus Fellinger
Journal:  BMC Psychiatry       Date:  2020-07-16       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.